Eunice Kennedy Shriver National Institute of Child Health and Human Development; Notice of Closed Meeting, 65861 [E8-26336]
Download as PDF
<![CDATA[
Federal Register / Vol. 73, No. 215 / Wednesday, November 5, 2008 / Notices
review/public/ using the docket
numbers listed in this notice.
Dated: October 27, 2008.
James D. Seligman,
Chief Information Officer, Centers for Disease
Control and Prevention.
[FR Doc. E8–26359 Filed 11–4–08; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Office of the Director (OD)/Office of the
Chief of Public Health Practice
(OCPHP)/Office of Minority Health and
Health Disparities (OMHD)
hsrobinson on PROD1PC76 with NOTICES
In accordance with Presidential
Executive Order No. 13175, November
6, 2000, and the Presidential
Memorandum of September 23, 2004,
Consultation and Coordination with
Indian Tribal Governments, the Centers
for Disease Control (CDC) OD/OSI/
OMHD announces the following
meeting and Tribal Consultation
Session:
Name: Tribal Consultation Advisory
Committee (TCAC) Meeting and the Biannual
Tribal Consultation Session.
Times and Dates: TCAC Meeting on
November 18–19, 2008 from 8 a.m.–5:30 p.m.
and the Biannual Tribal Consultation Session
on February 28, 2009 from 8–6 p.m.
Place: Hosted by Tohono O’odham Nation
at the Desert Diamond Casino & Hotel, 7350
S. Nogales Highway, Tucson, Arizona 85706,
Telephone: 1–877–777–4212.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 80 people.
Purpose: CDC established their Tribal
Consultation Policy in October of 2005 with
the primary purpose of providing guidance
across the agency to work effectively with
American Indian/Alaska Native (AI/AN)
tribes, communities, and organizations to
enhance AI/AN access to CDC programs. In
October of 2005, an Agency Advisory
Committee (CDC/ATSDR Tribal Consultation
Advisory Committee—TCAC) was
established to provide a complementary
venue wherein tribal representatives and
CDC staff will exchange information about
public health issues in Indian Country,
identifying urgent public health issues in
Indian Country, and discuss collaborative
approaches to these issues. Within the CDC
Consultation Policy, it is stated that CDC will
conduct government-to-government
consultation with elected tribal officials or
their designated representatives and also
confer with tribal and Alaska Native
organizations and AI/AN urban and rural
communities before taking actions and/or
making decisions that affect them.
Consultation is an enhanced form of
communication that emphasizes trust,
respect, and shared responsibility. It is an
VerDate Aug<31>2005
17:24 Nov 04, 2008
Jkt 217001
open and free exchange of information and
opinion among parties that leads to mutual
understanding and comprehension. CDC
believes that consultation is integral to a
deliberative process that results in effective
collaboration and informed decision making
with the ultimate goal of reaching consensus
on issues. Although formal responsibility for
the agency’s overall government-togovernment consultation activities rests
within the Office of the Director,
Coordinating Centers, Coordinating Offices,
and center leadership shall actively
participate in TCAC meetings, and HHSsponsored regional, and national tribal
consultation sessions as frequently as
possible.
Matters To Be Discussed: The TCAC will
convene their quarterly committee meeting
with discussions and presentations from
various CDC senior leadership on activities
and areas identified by tribal leaders as
priority public health issues. The Biannual
Tribal Consultation Session will engage CDC
Senior leadership from the Office of the
Director and various CDC Offices and
National Centers including the Financial
Management Office (FMO), National Center
for Environmental Health and the Agency for
Toxic Substances (NCEH/ATSDR),
Coordinating Office for Terrorism and
Preparedness and Emergency Response
(COTPER), National Center for Health
Marketing (NCHM), the Office of Chief of
Public Health Practice, and the Office of
Enterprise Communications (OEC).
Opportunities will be provided during the
Consultation Session for tribal testimony.
Tribal Leaders are encouraged to submit
written testimony by close of business on
November 7, 2008 to Capt. Pelagie (Mike)
Snesrud, Senior Tribal Liaison for Policy and
Evaluation, Office of Minority Health and
Health Disparities, 1600 Clifton Road, NE.,
Mailstop E–67, Atlanta, GA 30333, telephone
(404)498–2343, fax (404)498–2355, e-mail:
pws8@cdc.gov. Depending on the time
available it may be necessary to limit the
time of each presenter.
Please reference the Web link of
https://www.cdc.gov/omhd/TCAC/AAC.html
to review information about the TCAC and
CDC’s Tribal Consultation Policy.
For Further Information Contact: Capt.
Pelagie (Mike) Snesrud, Senior Tribal Liaison
for Policy and Evaluation, Office of Minority
Health and Health Disparities, 1600 Clifton
Road, NE., Mailstop E–67, Atlanta, GA
30333, telephone (404)498–2343, fax
(404)498–2355, e-mail: pws8@cdc.gov.
The Director, Management Analysis and
Services Office has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health and Human
Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel. Pharmacological
approaches to KNa channels and the FMRP
signaling pathway.
Date: December 5, 2008.
Time: 1 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Room 5B01, Rockville,
MD 20852. (Telephone Conference Call)
Contact Person: Anne Krey, PhD, Scientific
Review Administrator, Division of Scientific
Review, National Institute of Child Health
and Human Development, National Institutes
of Health, Bethesda, MD 20892, 301–435–
6908.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: October 29, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–26336 Filed 11–4–08; 8:45 am]
BILLING CODE 4140–01–P
Dated: October 27, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–26292 Filed 11–4–08; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
65861
E:\FR\FM\05NON1.SGM
05NON1
]]>Agencies
[Federal Register Volume 73, Number 215 (Wednesday, November 5, 2008)]
[Notices]
[Page 65861]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-26336]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health and
Human Development; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel. Pharmacological approaches to
KNa channels and the FMRP signaling pathway.
Date: December 5, 2008.
Time: 1 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6100 Executive Boulevard,
Room 5B01, Rockville, MD 20852. (Telephone Conference Call)
Contact Person: Anne Krey, PhD, Scientific Review Administrator,
Division of Scientific Review, National Institute of Child Health
and Human Development, National Institutes of Health, Bethesda, MD
20892, 301-435-6908.
(Catalogue of Federal Domestic Assistance Program Nos. 93.864,
Population Research; 93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation Research; 93.209,
Contraception and Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: October 29, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-26336 Filed 11-4-08; 8:45 am]
BILLING CODE 4140-01-P
